Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-21-035836

Director sold 2,500 shares at $4.34 ($10,850)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CLARKE JOHN K Director 2021-05-21 Sale −2,500 $4.34 $10,850 108,083 I
Open-market sales · 2,500 sh · avg $4.34 · $10,850
Loading xslF345X03/doc4.xml…